First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Håkan Mellstedt et al.|Leukemia|2018Cited by 52
Targeting the Receptor Tyrosine Kinase ROR1 by Small MoleculesMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Handbook of experimental pharmacology|2021Cited by 11
First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Blood|2015Cited by 6
Diffuse Large B Cell Lymphoma (DLBCL) Expresses ROR1 and a ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Tumor CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Amineh Ghaderi et al.|Blood|2019Cited by 6
ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) CellsHåkan Mellstedt, Mohammad Hojjat‐Farsangi, Amineh Ghaderi et al.|Blood|2019Cited by 5